Market Research Report
Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component (Oxygenator, Pumps), By Modality, By Patient Type, By Application, By Region, And Segment Forecasts, 2021 - 2028
|Published by||Grand View Research, Inc.||Product code||986174|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component (Oxygenator, Pumps), By Modality, By Patient Type, By Application, By Region, And Segment Forecasts, 2021 - 2028|
|Published: December 30, 2020||Content info: 110 Pages||
The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.
According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.
The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have been increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.
The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.